Financials
- Market Capitalization 15.65 M
- Employee 23
- Founded 2007
- CEO N/A
- Website www.citiuspharma.com
- Headquarter Nevada, United States
- FIGI BBG001QQH2N3
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-0.36
市销率
1.92
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 4629 | NCEL NewcelX Ltd. - Ordinary Shares | 3.29 USD | +0.30% | -6.27% | -8.86% | -35.24% | 15.78 M USD | ||
| 4631 | PLUR Pluri Inc. - Common Stock | 1.46 USD | -0.68% | -10.43% | -5.81% | -61.80% | 15.75 M USD | ||
| 4634 | ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.95 USD | +3.48% | +1.88% | +74.49% | +1465.79% | 15.62 M USD | ||
| 4635 | TPST Tempest Therapeutics, Inc. - Common Stock | 1.05 USD | -3.67% | -5.41% | +17.98% | -56.07% | 15.55 M USD |